BIOPROGRESS and its Major Shareholders

Products
Login
*


The products that Inyx develops and manufactures include:

Metered Dose Inhalers (MDIs) (CFC & HFA)
Dry Powder Inhalers (DPIs)
Metered Dose Pump Sprays (nasal & oral)
Hydrocarbon Foam Aerosols
Saline Aerosols
Sterile Solutions / Injectables
Solid Dose
Specific expertise has been developed in the above products as well as investment in automated filling and assembly equipment for cost-effective production.

Clients receive identification, selection or development of the most appropriate drug delivery systems, with access to the most technically advanced valves, cans and containers on the world market. A comprehensive range of pharmaceutical manufacturing, filling and packaging services, with a sophisticated QA system rigorously maintained to ensure consistent quality, are offered. Any combination of these services is available, customized to client's specifications.

Our production complex in Manati, Puerto Rico is regulatory compliant with the U.S. Food and Drug Administration and the U.K. Medicines Agency (MHRA), and our center in the United Kingdom is approved by the MHRA, the U.S. FDA, Canadian TPD and has received ISO 9001 accreditation.

Our sister company Ashton Pharmaceuticals Limited (located in Manchester, England) operates an MHRA approved facility and is involved in the manufacture of sterile solutions and injectable products and solid dose formulations. The solid dose facility is able to produce hormonal and steroidal products having full air suit capabilities. The sterile facility has recently undergone an €8 million upgrade which has significantly increased capacities. In addition to a 45% area increase and new air handling equipment, two new filling machines have been installed for ampoules and vials to complement the existing machines.